Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 48

1.

NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes.

Cirillo F, Ghiroldi A, Fania C, Piccoli M, Torretta E, Tettamanti G, Gelfi C, Anastasia L.

J Biol Chem. 2016 May 13;291(20):10615-24. doi: 10.1074/jbc.M116.719518. Epub 2016 Mar 17.

2.

Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis.

Shiga K, Takahashi K, Sato I, Kato K, Saijo S, Moriya S, Hosono M, Miyagi T.

Cancer Sci. 2015 Nov;106(11):1544-53. doi: 10.1111/cas.12810. Epub 2015 Oct 16.

3.

Role of plasma-membrane-bound sialidase NEU3 in clathrin-mediated endocytosis.

Rodriguez-Walker M, Vilcaes AA, Garbarino-Pico E, Daniotti JL.

Biochem J. 2015 Aug 15;470(1):131-44. doi: 10.1042/BJ20141550. Epub 2015 Jun 24.

PMID:
26251452
4.

Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.

Takahashi K, Hosono M, Sato I, Hata K, Wada T, Yamaguchi K, Nitta K, Shima H, Miyagi T.

Int J Cancer. 2015 Oct 1;137(7):1560-73. doi: 10.1002/ijc.29527. Epub 2015 Apr 1.

5.

Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation.

Yamamoto K, Takahashi K, Shiozaki K, Yamaguchi K, Moriya S, Hosono M, Shima H, Miyagi T.

PLoS One. 2015 Mar 24;10(3):e0120578. doi: 10.1371/journal.pone.0120578. eCollection 2015.

6.

Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum.

Hata K, Tochigi T, Sato I, Kawamura S, Shiozaki K, Wada T, Takahashi K, Moriya S, Yamaguchi K, Hosono M, Miyagi T.

Cancer Sci. 2015 Apr;106(4):383-9. doi: 10.1111/cas.12627. Epub 2015 Mar 9.

7.

Plasma membrane-associated sialidase confers cancer initiation, promotion and progression.

Miyagi T, Takahashi K, Shiozaki K, Yamaguchi K, Hosono M.

Adv Exp Med Biol. 2015;842:139-45. doi: 10.1007/978-3-319-11280-0_9. Review. No abstract available.

PMID:
25408341
8.

Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides.

Miyata M, Kambe M, Tajima O, Moriya S, Sawaki H, Hotta H, Kondo Y, Narimatsu H, Miyagi T, Furukawa K, Furukawa K.

Cancer Sci. 2011 Dec;102(12):2139-49. doi: 10.1111/j.1349-7006.2011.02086.x. Epub 2011 Oct 17.

9.

Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone.

Sandbhor MS, Soya N, Albohy A, Zheng RB, Cartmell J, Bundle DR, Klassen JS, Cairo CW.

Biochemistry. 2011 Aug 16;50(32):6753-62. doi: 10.1021/bi200449j.

PMID:
21675735
10.

Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis.

Albohy A, Li MD, Zheng RB, Zou C, Cairo CW.

Glycobiology. 2010 Sep;20(9):1127-38. doi: 10.1093/glycob/cwq077. Epub 2010 May 28.

PMID:
20511247
11.

Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells.

Mandal C, Tringali C, Mondal S, Anastasia L, Chandra S, Venerando B, Mandal C.

Int J Cancer. 2010 Jan 15;126(2):337-49. doi: 10.1002/ijc.24733.

12.

Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.

Tringali C, Lupo B, Cirillo F, Papini N, Anastasia L, Lamorte G, Colombi P, Bresciani R, Monti E, Tettamanti G, Venerando B.

Cell Death Differ. 2009 Jan;16(1):164-74. doi: 10.1038/cdd.2008.141. Epub 2008 Sep 26.

13.

Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.

Jin UH, Ha KT, Kim KW, Chang YC, Lee YC, Ko JH, Kim CH.

Biochim Biophys Acta. 2008 May;1780(5):757-63. doi: 10.1016/j.bbagen.2008.01.019. Epub 2008 Feb 20.

PMID:
18339327
14.

Roles of plasma membrane-associated sialidase NEU3 in human cancers.

Miyagi T, Wada T, Yamaguchi K.

Biochim Biophys Acta. 2008 Mar;1780(3):532-7. Epub 2007 Oct 2.

PMID:
18023981
16.

A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells.

Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T.

Oncogene. 2007 Apr 12;26(17):2483-90. Epub 2007 Mar 5.

PMID:
17334392
17.

Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice.

Yoshizumi S, Suzuki S, Hirai M, Hinokio Y, Yamada T, Yamada T, Tsunoda U, Aburatani H, Yamaguchi K, Miyagi T, Oka Y.

Metabolism. 2007 Mar;56(3):420-9.

PMID:
17292733
18.

Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling.

Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K, Saijo S, Miyagi T.

Biochem J. 2006 Mar 15;394(Pt 3):647-56.

19.

Molecular characterization of membrane type and ganglioside-specific sialidase (Neu3) expressed in E. coli.

Ha KT, Lee YC, Cho SH, Kim JK, Kim CH.

Mol Cells. 2004 Apr 30;17(2):267-73.

20.

Supplemental Content

Support Center